Sustained release ashwagandha extract

    公开(公告)号:US11911431B2

    公开(公告)日:2024-02-27

    申请号:US17347859

    申请日:2021-06-15

    发明人: Michael Lelah

    摘要: The present disclosure relates to compositions and methods for helping to manage the lingering symptoms and effects of COVID-19 after recovery. Specifically, the present disclosure relates to sustained release dietary and nutritional supplement compositions and methods to provide ongoing support and symptom management for individuals exposed to SARS-CoV-2 who contacted COVID-19 and later recovered but continue to experience after-effects or lingering symptoms. Specifically, the composition is based on a sustained release ashwagandha extract, alone in a therapeutically effective amount, or in combination with other ingredients.